Bone Marrow Stem Cell Exosomes Protect Lung Cells from Oxygen Damage by Regulating miR-23a-3p/Slc7a2 Pathway

Area of Science:

• Biomedical research
• Cell biology
• Neonatal medicine

Background:

• Mesenchymal stem cell exosomes (MSC-Exos) are vital for regulating alveolar epithelial cell functions.
• Hyperoxia exposure causes lung injury in neonatal rats, affecting alveolar epithelial type II cells (AECIIs).

Purpose of the Study:

• To investigate the regulatory mechanism of the miR-23a-3p/Slc7a2 axis via bone marrow MSC-derived exosomes in hyperoxia-induced AECII injury.
• To understand the role of this axis in neonatal rat lung injury models.

Main Methods:

• Utilized bioinformatics databases (miRBase, TargetScan) to identify microRNA-target gene interactions.
• Established in vitro and in vivo models of hyperoxia-induced lung epithelial cell injury.
• Performed dual-luciferase reporter assays to confirm the miR-23a-3p and Slc7a2 binding relationship.
• Constructed overexpression and siRNA plasmids for miR-23a-3p and Slc7a2.

Main Results:

• miR-23a-3p from BMSC exosomes directly targets Slc7a2 mRNA.
• miR-23a-3p inhibited hyperoxia-induced AECII apoptosis and promoted proliferation in vitro by suppressing Slc7a2.
• miR-23a-3p reduced reactive oxygen species (ROS) expression, while Slc7a2 promoted it.
• miR-23a-3p significantly ameliorated hyperoxia-induced lung tissue injury and apoptosis in neonatal rats.
• The miR-23a-3p/Slc7a2 axis modulated biochemical markers in AECIIs and neonatal rat serum.

Conclusions:

• miR-23a-3p within BMSC exosomes repairs hyperoxia-induced lung epithelial cell injury.
• This repair mechanism involves the regulation of its target gene, Slc7a2.